Hetero Drugs Introduces Anti-Ulcerant

Hetero Drugs Ltd, the flagship company of the Rs 500 crore Hyderabad-based Hetero Group, has introduced Rabeprazole, the latest anti-ulcerant drug, under a co-marketing arrangement with Lupin and German Remedies.

As per the arrangement, Hetero produces the drug for Lupin, German Remedies and itself, but markets it under three different brand names.

While Hetero launched the drug under the brand name Rabez, Lupin and German Remedies named it Rabilet and Happi, respectively.

Rabeprazole, claimed to be a highly effective proton pump inhibitor with less side effects, is patented by Takeda, Japan.